Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells.
Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells.
复制标题
个体长期造血干细胞的超高频重编程产生低体细胞变异诱导多能干细胞。
DOI:
10.1016/j.celrep.2019.02.021
复制
发表时间:
2019
期刊:
影响因子:
8.8
通讯作者:
Bouhassira,EricE
中科院分区:
文献类型:
--
作者:
Wang,Kai;Guzman,AnthonyK;Yan,Zi;Zhang,Shouping;Hu,MichaelY;Hamaneh,MehdiB;Yu,Yi-Kuo;Tolu,Seda;Zhang,Jinghang;Kanavy,HollyE;Ye,Kenny;Bartholdy,Boris;Bouhassira,EricE
Efficiency of reprogramming of human cells into induced pluripotent stem cells (iPSCs) has remained low. We report that individual adult human CD49f+long-term hematopoietic stem cells (LT-HSCs) can be reprogrammed into iPSCs at close to 50% efficiency using Sendai virus transduction. This exquisite sensitivity to reprogramming is specific to LT-HSCs, since it progressively decreases in committed progenitors. LT-HSC reprogramming can follow multiple paths and is most efficient when transduction is performed after the cells have exited G0. Sequencing of 75 paired skin fibroblasts/LT-HSC samples collected from nine individuals revealed that LT-HSCs contain a lower load of somatic single-nucleotide variants (SNVs) and indels than skin fibroblasts and accumulate about 12 SNVs/year. Mutation analysis revealed that LT-HSCs and fibroblasts have very different somatic mutation signatures and that somatic mutations in iPSCs generally exist prior to reprogramming. LT-HSCs may become the preferred cell source for the production of clinical-grade iPSCs.